Allumiqs is now an Alamar Biosciences Certified Service Provider


Bold science.
Beyond data.
Better together.

We shorten time-to-value in your discovery and development pipeline by delivering more than data – we provide direction and dedication to multiomics-driven research. Together, we don’t just build capacity, we advance your science and accelerate your impact.

Allumiqs Capabilities

Integrated omics and mass spec expertise.

We have the latest omics and LC-MS/MS technologies and a deep knowledge base to help you achieve your business and science goals.

Proteomics

Optimized and proven mass spec workflows to analyze, characterize, or identify proteins.

Learn more

Metabolomics

Explore small molecules, and profile your samples for known and unknown metabolites.

Learn more

Data Analytics

We help customers unlock the value and potential of their data with clearer, deeper insights.

Learn more

Allumiqs Solutions

Powering the progress of innovators.

In the business of drug development, results can be just as important as scientific breakthroughs. We have reimagined contract research optimization for the capital and resource-intensive discovery of drug targets to deliver meaningful data to you and your stakeholders.

We are a registered supplier on Scientist.com. If your organization uses Scientist.com for procurement, we would be happy to connect with you there.

powering research

Multi-service, integrated full scope solutions.

Omics-driven solutions that deliver critical decision-making data and insights to our customers.

Creating more than just transactional relationships with our customers, we are their outsourced innovation partner, enabling scientific and business success.

A world class partner/channel ecosystem focused on customer success.

Optimize Your Time-to-Biomarker & Budget

We deliver in-depth and robust protein biomarker readouts.  From functional insights to protein variants and a machine learning development model, our team ensures that the data we generate gets you to the next actionable step in your discovery pathway. 

Our approach is species agnostic and unlike epitope-based technologies, it is truly unbiased. 

Learn More

Integrated Translational Biology

At Allumiqs, we believe discovery flourishes through collaboration. That’s why we’re proud to partner with the Research Institute of the McGill University Health Centre (The Institute) to offer researchers a seamless bridge between cutting-edge bioanalytical expertise, solutions, and technologies. Together, we help you move beyond linear workflows and into a truly integrated discovery journey.

Learn More

High Sensitivity Biomarker Assays

Our High Sensitivity Biomarker Assay combines the power of the ARGO™ HT system with NULISA™—a next-gen immunoassay platform that achieves attomolar-level detection. Built on Alamar Biosciences’ dual-capture-and-release innovation, this assay delivers ultra-low detection limits and broad multiplexing for critical biomarkers in plasma, CSF and other biofluids, as well as some critical tissues such as brain homogenates.

Learn More

Allumiqs INSIGHTS

The latest FAQs, news, posters, and articles.

Frequently Asked ?s

Explore customers’ Frequently Asked Questions.

View all FAQs

Blog

A collection of articles and posts from the Allumiqs team and our partners.

Go to our Blog

Posters & Articles

A library of posters and publications highlighting our solutions.

View Posters & Articles

News & Views

Read the latest news and blog posts from Allumiqs.

Go to our Newsroom

Let’s Get in Touch

Subscribe to our newslist.

Fill out the quick form below and you can stay up-to-date on our latest blog posts, news, and posters.